Department of Internal Medicine, Fondazione Policlinico Universitario A.Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.
Emergency Department, Fondazione Policlinico Universitario A.Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.
Intern Emerg Med. 2021 Sep;16(6):1477-1486. doi: 10.1007/s11739-020-02582-y. Epub 2021 Jan 2.
Low thyroid function has been widely recognized as a potential cause of heart failure (HF), but the evidence about a possible association with in-hospital, all-cause mortality in patients with acute HF (AHF) is not consistent. This study sought to investigate the prevalence and prognostic role of hypothyroidism, overt and subclinical, and of low free-triiodothyronine (fT3) levels in patients hospitalized with AHF. We retrospectively analyzed consecutive 1018 patients who were hospitalized for AHF in a single academic medical center [Fondazione Policlinico A.Gemelli IRCCS, Rome, Italy] between January 1st 2016, and December 31st 2018. Patients were divided into three groups: normal thyroid function (n = 798), subclinical hypothyroidism (n = 105), and overt hypothyroidism (n = 115). The outcome was in-hospital, all-cause mortality. Patients were 81 years of age, 55% were females and nearly two-thirds of the patients were on New York Heart Association functional class III. The three most common cardiovascular comorbidities were coronary artery disease, hypertension, and atrial fibrillation with no differences across the three groups. Overall, 138 patients (14%) died during the hospital stay. The mortality rate was 27% among patients with overt hypothyroid, 17% among those with subclinical hypothyroidism, and 11% among euthyroid patients (p < 0.001). At a multivariate Cox regression model, overt hypothyroidism (HR 2.1, 95% CI 1.4-3.2) and fT3 levels < 1.8 pg/mL (HR 3.4, 95% CI 2.3-5.1) were associated with an increased likelihood of in-hospital death. No association was found with subclinical hypothyroidism. Among patients hospitalized with AHF, overt hypothyroidism and low fT3 levels are independent predictors of all-cause mortality during the hospital stay.
甲状腺功能低下已被广泛认为是心力衰竭(HF)的潜在病因,但关于甲状腺功能减退症与急性心力衰竭(AHF)患者住院期间全因死亡率之间可能存在关联的证据并不一致。本研究旨在探讨在因 AHF 住院的患者中,显性和亚临床甲状腺功能减退症及低游离三碘甲状腺原氨酸(fT3)水平的患病率及其预后作用。我们回顾性分析了 2016 年 1 月 1 日至 2018 年 12 月 31 日期间在意大利罗马 Fondazione Policlinico A.Gemelli IRCCS 单一学术医疗中心住院的 1018 例连续 AHF 患者。患者分为三组:甲状腺功能正常组(n=798)、亚临床甲状腺功能减退组(n=105)和显性甲状腺功能减退组(n=115)。结局为住院期间全因死亡率。患者的年龄为 81 岁,55%为女性,近三分之二的患者处于纽约心脏协会功能分级 III 级。最常见的三种心血管合并症是冠状动脉疾病、高血压和心房颤动,但三组之间没有差异。总体而言,138 例(14%)患者在住院期间死亡。显性甲状腺功能减退患者的死亡率为 27%,亚临床甲状腺功能减退患者为 17%,甲状腺功能正常患者为 11%(p<0.001)。在多变量 Cox 回归模型中,显性甲状腺功能减退症(HR 2.1,95%CI 1.4-3.2)和 fT3 水平<1.8pg/mL(HR 3.4,95%CI 2.3-5.1)与住院期间死亡的可能性增加相关。亚临床甲状腺功能减退症与死亡无关。在因 AHF 住院的患者中,显性甲状腺功能减退症和低 fT3 水平是住院期间全因死亡率的独立预测因素。